Dr. James Campagna, M.D.
What this data tells you about Dr. Campagna
Dr. James Campagna is an anesthesiology specialist in Valdosta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Campagna performed 2,734 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Campagna received a total of $2,117 from 22 pharmaceutical and/or device companies across 143 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Campagna is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary — 2023
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
792 | $61 | $124 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
734 | $34 | $53 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
654 | $112 | $229 |
| Chlamydia pneumoniae nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of Chlamydia pneumoniae bacteria in a sample. |
162 | $34 | $53 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
145 | $153 | $313 |
| Respiratory virus nucleic acid test, 3-5 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of respiratory viruses. The test analyzes 3 to 5 specific viral targets. |
132 | $140 | $214 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
56 | $50 | $77 |
| COVID-19 nucleic acid test, high throughput A laboratory test that detects the genetic material of the SARS-CoV-2 virus using an amplified probe technique. This method utilizes high-throughput technologies to process samples. |
26 | $74 | $150 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
21 | $242 | $494 |
| Influenza virus nucleic acid detection test A laboratory test that uses nucleic acid technology to detect the presence of influenza virus types or subtypes in a sample. |
12 | $50 | $77 |
Industry Payment Transparency
Open Payments through 2022 ↗Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2022)
All-time payments by company (2018-2022) ›
Associated products mentioned in payments ›
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2022 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Campagna is a mixed practice specialist, with above-average Medicare volume (top 3% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Campagna experienced with drug screening test?
Does Dr. Campagna receive payments from pharmaceutical companies?
How do Dr. Campagna's costs compare to other anesthesiologists in Valdosta?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology